The first new Alzheimer’s treatment in more than 20 years was hailed as a breakthrough when regulators approved it more than four months ago, but…
Photobiomodulation (PBM) offers exciting opportunities for improving the life of patients with a diverse range of brain disorders. In this special collection of articles in…
University of Virginia School of Medicine researchers have revealed a vital but previously unknown role for immune cells that protect the brain from disease and…
At the beginning of neurodegenerative disease, the immune cells of the brain—the “microglia”—take up glucose, a sugar molecule, to a much greater extent than hitherto…
It has long been known that type 2 diabetes is associated with a higher risk of developing dementia disease. However, as for the risk of…
New research from the Florida State University College of Medicine found that changes in the brain associated with Alzheimer’s disease are often visible early on…
The structural integrity of the brain’s white matter as measured with an advanced MRI technique is lower in cognitively normal people who carry a genetic…
Research conducted by Ph.D student Mohamed Raâfet Ben Khedher and postdoctoral researcher Mohamed Haddad of the Institut national de la recherche scientifique (INRS) has shown…
The Baycrest-developed, at-home Cogniciti Brain Health Assessment performs as well as a widely used, clinician-led test at assessing patients’ cognitive health, reports a new study.
A commonly available oral diuretic pill approved by the U.S. Food and Drug Administration may be a potential candidate for an Alzheimer’s disease treatment for…